105 related articles for article (PubMed ID: 24373162)
21. Hematopoietic stem cell transplantation in children with hematological malignancies across HLA barriers--reasonable alternative?
Sedlácek P; Starý J; Vodváková S; Poloucková A; Gasová Z; Marinov I; Formánková R
Neoplasma; 2001; 48(4):302-6. PubMed ID: 11712683
[TBL] [Abstract][Full Text] [Related]
22. Intestinal transplantation in children: preliminary experience in Paris.
Goulet O; Jan D; Lacaille F; Colomb V; Michel JL; Damotte D; Jouvet P; Brousse N; Faure C; Cézard JP; Sarnacki S; Peuchmaur M; Hubert P; Ricour C; Révillon Y
JPEN J Parenter Enteral Nutr; 1999; 23(5 Suppl):S121-5. PubMed ID: 10483912
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of tacrolimus, methotrexate, and prednisolone as a graft-versus-host disease prophylaxis in non-T-cell-depleted haploidentical hematopoietic stem cell transplantation for children.
Mochizuki K; Kikuta A; Ito M; Sano H; Akaihata M; Kobayashi S; Ohto H; Hosoya M
Clin Transplant; 2011; 25(6):892-7. PubMed ID: 21070366
[TBL] [Abstract][Full Text] [Related]
24. Microvillous inclusion disease: how to improve the prognosis of a severe congenital enterocyte disorder.
Halac U; Lacaille F; Joly F; Hugot JP; Talbotec C; Colomb V; Ruemmele FM; Goulet O
J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):460-5. PubMed ID: 21407114
[TBL] [Abstract][Full Text] [Related]
25. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome after haploidentical stem cell transplantation in children.
Lang P; Greil J; Bader P; Handgretinger R; Klingebiel T; Schumm M; Schlegel PG; Feuchtinger T; Pfeiffer M; Scheel-Walter H; Führer M; Martin D; Niethammer D
Blood Cells Mol Dis; 2004; 33(3):281-7. PubMed ID: 15528145
[TBL] [Abstract][Full Text] [Related]
27. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
[TBL] [Abstract][Full Text] [Related]
28. [T-cell-depleted HLA non-identical bone marrow transplantation in the child: prevention of graft-versus-host reaction by administration of donor T lymphocytes alloreactive against the recipient].
Cavazzana-Calvo M; André-Schmutz I; Hacein-Bey S; Schindler J; Vitetta H; Dupuis S; Quartier P; Chedeville G; Vilmer E; Casanova JL; Buffet R; Caillat-Zucman S; Radford I; Le Deist F; Fischer A
J Soc Biol; 2001; 195(1):65-8. PubMed ID: 11530503
[TBL] [Abstract][Full Text] [Related]
29. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.
Baron F; Lechanteur C; Willems E; Bruck F; Baudoux E; Seidel L; Vanbellinghen JF; Hafraoui K; Lejeune M; Gothot A; Fillet G; Beguin Y
Biol Blood Marrow Transplant; 2010 Jun; 16(6):838-47. PubMed ID: 20109568
[TBL] [Abstract][Full Text] [Related]
30. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
Großekatthöfer M; Güclü ED; Lawitschka A; Matthes-Martin S; Mann G; Minkov M; Peters C; Seidel MG
Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
[TBL] [Abstract][Full Text] [Related]
31. Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma.
Levenga H; Schaap N; Maas F; Esendam B; Fredrix H; Greupink-Draaisma A; de Witte T; Dolstra H; Raymakers R
Biol Blood Marrow Transplant; 2010 Mar; 16(3):320-32. PubMed ID: 19835972
[TBL] [Abstract][Full Text] [Related]
32. The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants.
Shah AJ; Kapoor N; Crooks GM; Weinberg KI; Azim HA; Killen R; Kuo L; Rushing T; Kohn DB; Parkman R
Biol Blood Marrow Transplant; 2007 May; 13(5):584-93. PubMed ID: 17448918
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children.
Kondo M; Kojima S; Horibe K; Kato K; Matsuyama T
Bone Marrow Transplant; 2001 Apr; 27(7):727-30. PubMed ID: 11360113
[TBL] [Abstract][Full Text] [Related]
34. Current status of graft-versus-host disease after intestinal transplantation.
Ganoza A; Mazariegos GV; Khanna A
Curr Opin Organ Transplant; 2019 Apr; 24(2):199-206. PubMed ID: 30762668
[TBL] [Abstract][Full Text] [Related]
35. Mismatched related hematopoietic stem cell transplantation in primary immunodeficiency.
Wahadneh AM; Bin Dahman HA; Abu Shukear ME; Habahbeh ZM; Ajarmeh MA; Zyood RM; Habashneh MS
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1137-43. PubMed ID: 24231474
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia.
Hutspardol S; Sirachainan N; Anurathapan U; Pakakasama S; Songdej D; Chuansumrit A; Sirireung S; Panthangkool W; Hongeng S
J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S18-24. PubMed ID: 23724451
[TBL] [Abstract][Full Text] [Related]
38. A syndrome involving immunodeficiency and multiple intestinal atresias.
Rothenberg ME; White FV; Chilmonczyk B; Chatila T
Immunodeficiency; 1995; 5(3):171-8. PubMed ID: 7749436
[TBL] [Abstract][Full Text] [Related]
39. Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine.
Ahmed N; Leung KS; Rosenblatt H; Bollard CM; Gottschalk S; Myers GD; Carrum G; Heslop HE; Brenner MK; Krance RA
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1298-304. PubMed ID: 18940685
[TBL] [Abstract][Full Text] [Related]
40. The use of sirolimus as a rescue therapy in pediatric intestinal transplant recipients.
Andres AM; Lopez Santamaría M; Ramos E; Hernandez F; Prieto G; Encinas J; Leal N; Molina M; Sarría J; Tovar J
Pediatr Transplant; 2010 Nov; 14(7):931-5. PubMed ID: 20946188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
